text-only page produced automatically by LIFT Text Transcoder Skip all navigation and go to page contentSkip top navigation and go to directorate navigationSkip top navigation and go to page navigation
National Science Foundation Home National Science Foundation - Biological Sciences (BIO)
Environmental Biology (DEB)
design element
DEB Home
About DEB
Funding Opportunities
Awards
News
Events
Discoveries
Publications
Career Opportunities
Additional BIO Resources
Supplements & Other Opportunities
See Additional DEB Resources
View DEB Staff
BIO Organizations
Biological Infrastructure (DBI)
Environmental Biology (DEB)
Emerging Frontiers (EF)
Integrative Organismal Systems (IOS)
Molecular and Cellular Biosciences (MCB)
Proposals and Awards
Proposal and Award Policies and Procedures Guide
  Introduction
Proposal Preparation and Submission
bullet Grant Proposal Guide
  bullet Grants.gov Application Guide
Award and Administration
bullet Award and Administration Guide
Award Conditions
Other Types of Proposals
Merit Review
NSF Outreach
Policy Office
Additional DEB Resources
BIO Dear Colleague Letters
BIO Reports
Interdisciplinary Research
Merit Review
Merit Review Broader Impacts Criterion: Representative Activities
Image Credits
Other Site Features
Special Reports
Research Overviews
Multimedia Gallery
Classroom Resources
NSF-Wide Investments

Email this pagePrint this page
All Images


Press Release 12-129
Elegant Delivery

Sophisticated technique for delivering multiple cancer treatments may solve frustrating hurdle for combined drug therapies

Back to article | Note about images

Illustration depicting the nanolipogel administering its immunotherapy cargo.

This illustration depicts the nanolipogel, developed at Yale University with NSF support, administering its immunotherapy cargo. The light-blue spheres within the blood vessels and the cutaway sphere in the foreground, are the nanolipogels (NLGs). As the NLGs break down, they release IL-2 (the green specks), which helps recruit and activate a body's immune response (the purple, sphere-like cells). The tiny, bright blue spheres are the additional treatment, a cancer drug that inhibits TGF-beta (one of the cancer's defense chemicals).

Credit: Nicolle Rager Fuller, NSF


Download the high-resolution JPG version of the image. (1.4 MB)

Use your mouse to right-click (Mac users may need to Ctrl-click) the link above and choose the option that will save the file or target to your computer.

Yale University engineering professor Tarek Fahmy joined NSF to explain a novel, nanoscale, drug-delivery system that bundles powerful anti-cancer medicines into a single, treatment. The new approach solves several problems that hinder current drug delivery systems and has now proven effective in animal models.

Credit: National Science Foundation

 



Email this pagePrint this page
Back to Top of page